Tom Gayner Markel Group
Tom Gayner is the CEO of Markel Group and long-time steward of its public equity portfolio. Often compared to a smaller-scale Berkshire-style model, Markel combines insurance operations with a carefully selected book of common stocks. Gayner is known for a patient, owner-oriented philosophy and for writing clearly about compounding, culture, and long-term business ownership.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$9.82M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$9.32M |
| 3 |
Goldman Sachs
GS
|
+$4.96M |
| 4 |
Blackstone
BX
|
+$2.96M |
| 5 |
Brookfield
BN
|
+$2.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$31.8M |
| 2 |
Core Laboratories
CLB
|
+$11.1M |
| 3 |
NXP Semiconductors
NXPI
|
+$3.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 32.25% |
| 2 | Consumer Discretionary | 17.93% |
| 3 | Industrials | 11.37% |
| 4 | Healthcare | 11.24% |
| 5 | Consumer Staples | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Baxter International
BAX
$13.6B
| $1.38M | 0.03% |
22,000
| – | – |
|
127
W.R. Berkley
WRB
$25.5B
| $1.2M | 0.02% |
60,750
+33,750
| +125% | +$676K |
|
128
International Flavors & Fragrances
IFF
$21.5B
| $1.14M | 0.02% |
+8,000
| New | +$1.1M |
|
129
Atlanta Braves Holdings Series A
BATRA
$3.64B
| $1.08M | 0.02% |
42,600
| – | – |
|
130
Microchip Technology
MCHP
$41.3B
| $718K | 0.01% |
+16,000
| New | +$671K |
|
131
Goodyear
GT
$1.72B
| $665K | 0.01% |
+20,000
| New | +$650K |
|
132
Bristol-Myers Squibb
BMY
$137B
| $637K | 0.01% |
10,000
| – | – |
|
133
Hormel Foods
HRL
$13.1B
| $611K | 0.01% |
19,000
+12,000
| +171% | +$392K |
|
134
Booking.com
BKNG
$158B
| $366K | 0.01% |
5,000
| – | – |
|
135
Merck
MRK
$376B
| $359K | 0.01% |
5,869
| – | – |
|
136
Liberty Latin America Class A
LILA
$1.66B
| $350K | 0.01% |
22,990
| – | – |
|
137
HEICO Corp
HEI
$49.6B
| $337K | 0.01% |
7,324
| – | – |
|
138
Novartis
NVS
$302B
| $318K | 0.01% |
4,129
| – | – |
|
139
SLB Ltd
SLB
$79.9B
| $279K | 0.01% |
4,000
| – | – |
|
|
140
Core Laboratories
CLB
$574M
| – | – |
-110,000
| Closed | -$11.1M |
|
|
141
NXP Semiconductors
NXPI
$56.9B
| – | – |
-35,000
| Closed | -$3.83M |
|
Similar funds
Tom Gayner's Q3 2017 Portfolio in Review
As of Q3 2017, Tom Gayner held 141 positions worth $5.02B, up 7.1% from $4.69B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 3.5%. Tom Gayner opened 3 new positions and exited 2, leaving the 141-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Tom Gayner's largest Q3 2017 buy was International Flavors & Fragrances: 8,000 shares worth $1.14M.
- Tom Gayner added most to Amazon in Q3 2017, an estimated $9.82M increase.
- Tom Gayner's biggest Q3 2017 reduction was ExxonMobil, cutting an estimated $31.8M.
- Tom Gayner fully exited Core Laboratories in Q3 2017, selling an estimated $11.1M.
- Tom Gayner's ten largest holdings make up 43% of its $5.02B portfolio in Q3 2017.
- Tom Gayner opened 3 new positions and closed 2 in Q3 2017.
- Tom Gayner's portfolio value rose 7.1% quarter-over-quarter to $5.02B.
Based on Markel Group's 13F filing for Q3 2017, filed 27 Oct 2017.